Funding
← Back to your selection

HSG

Activity from announced rounds

Activity in this selectionnext-frontier-capital-8a6b89d2

HSG is the investment firm formerly known as Sequoia China, as identified in Clipto’s financing release. Full-Life also names it in its own announcement.

Recorded funding activity

The recorded activity includes Anew’s AI drug discovery, Clipto’s video-library tools and Math Magic’s generation of 3D models and physical products. Named HSG funds retain their separate identities.

Sources
Rounds participated in
11
Confirmed lead rounds
1
9 roles undisclosed
New companies
11
First participation on record · 0 follow-on
Funding in participating rounds
$993M
9 disclosed · full round size, not this investor’s share

By stage

Series A5
Undisclosed5
Growth1

By primary sector

AI3
Biotech3
Healthtech2
Consumer1
Fintech1
1 more
Robotics1

By country

China7
United States3
Singapore1

Rounds

11 in this selection
Anew Labs

An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.

$290MFunding
Lead
Clipto

Clipto builds AI tools for searching and working with video and audio libraries.

$15MFunding
Participant
Math Magic

AI platform generating 3D models and personalized physical products

UndisclosedSeries A+
Role not disclosed
Full-Life Technologies

Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing

$150MSeries D+Debt
Role not disclosed
ROBOTERA

Builds humanoid robots with fully in-house hardware for logistics and industrial deployment at scale

$200MGrowth
Role not disclosed
Pulnovo Medical

Develops interventional therapies for pulmonary hypertension and heart failure

$100MStrategic
Role not disclosed
Dify

Helps teams build deploy and operate production-grade AI applications and agentic workflows

$30MPre-Series A
Role not disclosed
KAST

Provides USD-denominated accounts and global financial tools built on stablecoin rails

$80MSeries A
Role not disclosed
Spiro Medical

Develops a Pulmonary Neuromodulation System for asthma treatment

$67MSeries A
Role not disclosed